Search Results - tyler+heitmann

1 Results Sort By:
Non-acid IP6K Inhibitors
Unmet Need Globally, in 2021, there were approximately 537 million cases of diabetes which resulted in about 6.7 million deaths and $966 billion of healthcare expenditure (IDF). About 95% of diabetes cases are type 2 diabetes (T2D), which is characterized by either impaired insulin production or insulin resistance, and primarily occurs in adults. There...
Published: 9/27/2024   |   Inventor(s): Tyler Heitmann, James Barrow
Keywords(s):  
Category(s): Clinical and Disease Specializations > Diabetes, Clinical and Disease Specializations > Diabetes > Type 2 Diabetes, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities > Targets
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum